抑制壁酸D-丙氨酰化可逆转MRSA耐药性
该研究探索壁酸D-丙氨酰化(由dlt操纵子基因产物介导)是否可作为药物靶点以克服MRSA对β-内酰胺类抗生素的耐药性。研究通过遗传或化学抑制Dlt系统,在临床MRSA菌株中检测多种β-内酰胺类抗生素的MIC和杀菌效果,并评估化学抑制剂对感染MRSA的幼虫的保护作用及对生物膜的抑制/根除能力。结果显示,抑制D-丙氨酰化可使MRSA对β-内酰胺类重新敏感,其中与亚胺培南联用效果最显著,中位MIC从16降至0.25 mg/L。
要点
- 遗传失活或化学抑制Dlt系统均可重新敏化MRSA对β-内酰胺类抗生素。
- 抑制剂与亚胺培南联用使中位MIC从16降至0.25 mg/L。
- 该联合方案对部分菌株具杀菌作用,并显著保护幼虫免受致死性MRSA感染。
核心结论
- 靶向Dlt系统的高效D-丙氨酰化抑制剂有望作为治疗佐剂,尤其与碳青霉烯类联用,恢复该类药物对MRSA的疗效。
研究设计与样本
- 在具有遗传或化学诱导D-丙氨酰化缺陷的临床MRSA菌株面板中监测多种β-内酰胺类抗生素的MIC和杀菌效果。
- 分析化学抑制剂对感染MRSA的Galleria mellonella幼虫的拯救效率及其预防或根除金黄色葡萄球菌生物膜的能力。
主要发现
- 遗传失活Dlt系统或化学抑制可重新敏化MRSA对β-内酰胺类抗生素。
- 在13株菌中,抑制剂与亚胺培南联用效果最显著,中位MIC从16降至0.25 mg/L。
- 该联合方案对部分菌株具杀菌作用,并显著保护G. mellonella幼虫免受致死性MRSA感染。
- 失活D-丙氨酰化可增强亚胺培南抑制和/或根除生物膜的效果。
关键数值与推荐
- 在13株临床MRSA菌株中,抑制剂与亚胺培南联用使中位MIC从16 mg/L降至0.25 mg/L。
临床怎么用
- D-丙氨酰化抑制剂尤其与碳青霉烯类联用,可能作为治疗佐剂恢复β-内酰胺类对MRSA的疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: MRSA are high-priority multidrug-resistant pathogens. Although there are still some antibiotics active against MRSA, continuous efforts to discover new antibiotics and treatment strategies are needed because resistance to these new drugs has already been reported. OBJECTIVES: Here we explore if d-alanylation of teichoic acids (TAs) mediated by the dlt operon gene products might be a druggable target to overcome β-lactam-resistance of MRSA. METHODS: MICs and bactericidal effects of several β-lactam antibiotics were monitored in a panel of clinical MRSA strains with genetic or chemically induced deficiency in d-alanylation of TAs. Efficiency of the chemical inhibitor to rescue MRSA-infected larvae of Galleria mellonella as well as its ability to prevent or eradicate biofilms of S. aureus were analysed. RESULTS: Genetic inactivation of the Dlt system or its chemical inhibition re-sensitizes MRSA to β-lactams. Among the 13 strains, the most pronounced effect was obtained using the inhibitor with imipenem, reducing the median MIC from 16 to 0.25 mg/L. This combination was also bactericidal in some strains and significantly protected G. mellonella larvae from lethal MRSA infections. Finally, inactivation of d-alanylation potentiated the effect of imipenem on inhibition and/or eradication of biofilm. CONCLUSIONS: Our combined results show that highly efficient inhibitors of d-alanylation of TAs targeting enzymes of the Dlt system should be promising therapeutic adjuvants, especially in combination with carbapenems, for restoring the therapeutic efficacy of this class of antibiotics against MRSA.
引用
- Coupri D, Verneuil N, Hartke A, et al. Inhibition of d-alanylation of teichoic acids overcomes resistance of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2021. PMID: 34450626. doi:10.1093/jac/dkab287
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。